2021
DOI: 10.1002/hed.26838
|View full text |Cite
|
Sign up to set email alerts
|

Treatment outcomes of neoadjuvant chemotherapy and transoral robotic surgery in locoregionally advanced laryngopharyngeal carcinoma

Abstract: Background: We aimed to identify the optimal indications of neoadjuvant chemotherapy (NACT) and transoral robotic surgery (TORS) in patients with locoregionally advanced (T3-4 or N2-3) head and neck cancer (HNC).Methods: A total of 50 patients were included in the study. Results: T1 was identified in seven cases, T2 in 19, T3 in 22, and T4 in 2. N0 was identified in nine cases, N1 in 18, N2 in 22, and N3 in 1. There were 25 patients (50%) with complete remission of the primary lesion and 25 patients (50%) with… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
2
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
5

Relationship

1
4

Authors

Journals

citations
Cited by 6 publications
(3 citation statements)
references
References 14 publications
0
2
0
Order By: Relevance
“…Transoral surgery combined with NAC has been performed for advanced HPSCC, and favorable oncological and functional outcomes have been reported. [8][9][10] In our institution, both classical surgery and transoral surgery combined with NAC are used to treat HNSCC patients. Since OPEN TORS Fig.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Transoral surgery combined with NAC has been performed for advanced HPSCC, and favorable oncological and functional outcomes have been reported. [8][9][10] In our institution, both classical surgery and transoral surgery combined with NAC are used to treat HNSCC patients. Since OPEN TORS Fig.…”
Section: Discussionmentioning
confidence: 99%
“…Studies have reported outcomes of transoral surgery and compared its oncological and functional results with conventional treatments. [8][9][10] In the case of advanced HPSCC, new therapies combining neoadjuvant chemotherapy (NAC) and transoral robotic surgery (TORS) have shown promising oncological and functional outcomes. However, limitations such as single-institution studies and retrospective designs introduce selection bias, and comprehensive investigations on HPSCC's natural course, prognostic factors, and treatment results are lacking due to the low incidence of HPSCC.…”
Section: Introductionmentioning
confidence: 99%
“…Its advantages include a wider 3D magnified view, the capacity to visualize ‘around the corner’, and finely controlled movements facilitated by flexible robotic arms and a tremor-filtering system 259 , 260 . Compared to traditional open treatment, transoral robotic surgery offers a minimally invasive approach, expediting patient recovery and improving aesthetic and functional preservation 261 263 . However, transoral robotic surgery can be more time-consuming than conventional surgery, necessitates a substantial initial investment, and presents a steep learning curve for surgeons 264 .…”
Section: Precise Head and Neck Oncology Surgerymentioning
confidence: 99%